ReviewCancer medicine2017

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).

Rachel A Sabol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.